{"organizations": [], "uuid": "0f575bcad8e01ec53cbef33b94e0818b9dd6afe8", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180311.html", "section_title": "Archive News &amp; Video for Sunday, 11 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-guangzhou-baiyunshan-pharmaceutica/brief-guangzhou-baiyunshan-pharmaceutical-holdings-unit-receives-gmp-certificate-idUSL3N1QU1AQ", "country": "US", "domain_rank": 408, "title": "BRIEF-Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.892, "site_type": "news", "published": "2018-03-12T08:51:00.000+02:00", "replies_count": 0, "uuid": "0f575bcad8e01ec53cbef33b94e0818b9dd6afe8"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-guangzhou-baiyunshan-pharmaceutica/brief-guangzhou-baiyunshan-pharmaceutical-holdings-unit-receives-gmp-certificate-idUSL3N1QU1AQ", "ord_in_thread": 0, "title": "BRIEF-Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate", "locations": [], "entities": {"persons": [], "locations": [{"name": "guangzhou", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "guangzhou baiyunshan pharmaceutical holdings co ltd", "sentiment": "negative"}, {"name": "gmp", "sentiment": "negative"}, {"name": "baiyunshan pharmaceutical holdings", "sentiment": "negative"}, {"name": "xingqun pharmaceutical co ltd", "sentiment": "none"}, {"name": "beijing headline news", "sentiment": "none"}, {"name": "guangdong food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 12(Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd\n* Says coâ€™s unit Guangzhou Baiyunshan Xingqun Pharmaceutical Co Ltd received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration\n* Says valid period is until Feb. 28, 2023\nSource text in Chinese: goo.gl/rTeXKY\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["https://goo.gl/rTeXKY", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-12T08:51:00.000+02:00", "crawled": "2018-03-12T13:06:32.005+02:00", "highlightTitle": ""}